FIELD: medicine, pharmacology.
SUBSTANCE: agent represents flavolignans chosen from silybinine, silydianine, silycrystine, dehydrosilybinine, their mixtures or extracts prepared from plant spotted milk thistle (Silybium marianum (L.) Gaertn) containing these components. Agent is used for inhibition of excessive or pathological proliferation of vascular endothelium. Proposed agent expands assortment of agents directed for treatment pathologies associated with angiogenesis disorders. Invention can be used in development of medicinal preparations used in therapy of pathologies associated with angiogenesis disorders, namely, for inhibition of excessive or pathological proliferation of vascular endothelium.
EFFECT: valuable medicinal properties of agent.
1 tbl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR THERAPY OF HEPATIC PATHOLOGIES AND ONCOLOGICAL DISEASES | 2008 |
|
RU2379046C1 |
| ANTITUMOR LIPOSOMAL PREPARATION WITH DIRECTED EFEFCT | 2005 |
|
RU2292898C1 |
| AGENT AND METHOD FOR TREATMENT AND PROPHYLAXIS OF ONCOLOGY DISEASES | 2005 |
|
RU2283658C1 |
| BIOCOMPOSITION POSSESSING ANTITOXIC AND ANTI-ADAPTOSIS EFFECT, PROPHYLACTIC BIOLOGICAL SUPPLEMENT BASED ON THEREOF | 2005 |
|
RU2319498C2 |
| METHOD OF OBTAINING DRY EXTRACT OF MILK THISTLE | 2009 |
|
RU2424818C1 |
| COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF ONCOLOGICAL DISEASE | 2005 |
|
RU2311917C2 |
| METHOD FOR OBTAINING SUBSTANCE OF ANTIOXIDANT ACTION | 2002 |
|
RU2209063C1 |
| PREVENTIVE COMPOSITION BASED ON SUBSTANCES OF PHENOL NATURE | 2008 |
|
RU2354395C1 |
| METHOD FOR PRODUCING SILYMARIN AND NANOSELENIUM AGENT HAVING INHIBITORY ACTION OF TUMOUR CELL GROWTH | 2014 |
|
RU2549494C1 |
| METHOD FOR PRODUCING SAINT-MARY-THISTLE SYRUP | 2016 |
|
RU2647452C1 |
